A prospective split-face double-blind randomized placebo-controlled trial to assess the efficacy of methyl aminolevulinate + red-light in patients with facial photodamage

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 1, 2011, Pages 49-58

  Sanclemente, G ^a   Medina, L ^a   Villa, J F ^a   Barrera, L M ^a   Garcia, H I ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

efficacy; facial photodamage; methyl aminolevulinate; randomized controlled trial; red light

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; ANTIBIOTIC AGENT; CETAPHIL; CORTICOSTEROID; PARACETAMOL; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; ERYTHEMA; FACE; FACE EDEMA; FACE ERYTHEMA; FEMALE; HUMAN; LIGHT DAMAGE; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RED LIGHT; SCORING SYSTEM; SIDE EFFECT; SKIN BIOPSY; SKIN PIGMENTATION; TELANGIECTASIA; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; AMINOLEVULINIC ACID; DOUBLE-BLIND METHOD; FACE; FEMALE; HUMANS; MIDDLE AGED; PHOTOTHERAPY; PLACEBOS; PROSPECTIVE STUDIES; SKIN AGING;

EID: 78650011221     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03687.x     Document Type: Article

References (25)

1. Bernstein EF,. Chemical peels. Semin Cutan Med Surg 2002; 21: 27-45.
2. Bernstein EF,. The new-generation, high-energy, 595-nm, long pulse-duration pulsed-dye laser improves the appearance of photodamaged skin. Lasers Surg Med 2007; 39: 157-163.
3. Kligman AM, Leyden JJ,. Treatment of photoaged skin with topical tretinoin. Skin Pharmacol 1993; 6 (Suppl 1): 78-82.
4. Leyden JJ, Grove GL, Grove MJ, Thorne EG, Lufrano L,. Treatment of photodamaged facial skin with topical tretinoin. J Am Acad Dermatol 1989; 21: 638-644.
5. Alster TS, Nanni CA, Williams CM,. Comparison of four carbon dioxide resurfacing lasers. A clinical and histopathologic evaluation. Dermatol Surg 1999; 25: 153-158.
6. Alster TS,. Clinical and histologic evaluation of six erbium:YAG lasers for cutaneous resurfacing. Lasers Surg Med 1999; 24: 87-92.
7. Jorgensen GF, Hedelund L, Haedersdal M,. Long-pulsed dye laser versus intense pulsed light for photodamaged skin: a randomized split-face trial with blinded response evaluation. Lasers Surg Med 2008; 40: 293-299.
8. Weiss JS, Shavin JS, Nighland M, Grossman R,. Tretinoin microsphere gel 0.1% for photodamaged facial skin: a placebo-controlled trial. Cutis 2006; 78: 426-432.
9. Samuel M, Brooke RC, Hollis S, Griffiths CE,. Interventions for photodamaged skin. Cochrane Database Syst Rev 2005: CD001782.
10. Waibel J, Beer K, Narurkar V, Alster T,. Preliminary observations on fractional ablative resurfacing devices: clinical impressions 2. J Drugs Dermatol 2009; 8: 481-485.
11. Doherty SD, Doherty CB, Markus JS, Markus RF,. A paradigm for facial skin rejuvenation. Facial Plast Surg 2009; 25: 245-251.
12. Alexiades-Armenakas MR, Dover JS, Arndt KA,. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol 2008; 58: 719-737.
13. Babilas P, Landthaler M, Szeimies RM,. Photodynamic therapy in dermatology. Eur J Dermatol 2006; 16: 340-348.
14. Kalka K, Merk H, Mukhtar H,. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000; 42: 389-413.
15. Touma D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA,. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 2004; 140: 33-40.
16. Avram DK, Goldman MP,. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol 2004; 3: S36-S39.
17. Ruiz-Rodriguez R, Sanz-Sanchez T, Cordoba S,. Photodynamic photorejuvenation. Dermatol Surg 2002; 28: 742-744.
18. Goldman M, Atkin D,. ALA/PDT in the treatment of actinic keratosis: spot versus confluent therapy 3. J Cosmet Laser Ther 2003; 5: 107-110.
19. Alster TS, Tanzi EL, Welsh EC,. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol 2005; 4: 35-38.
20. Dover JS, Bhatia AC, Stewart B, Arndt KA,. Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging. Arch Dermatol 2005; 141: 1247-1252.
21. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA,. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg 2006; 32: 795-801.
22. Ruiz-Rodriguez R, Lopez L, Candelas D, Pedraz J,. Photorejuvenation using topical 5-methyl aminolevulinate and red light. J Drugs Dermatol 2008; 7: 633-637.
23. Karch FE, Lasagna L,. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247-254.
24. Fritsch C, Ruzicka T,. Fluorescence diagnosis and photodynamic therapy in dermatology from experimental state to clinic standard methods. J Environ Pathol Toxicol Oncol 2006; 25: 425-439.
25. Kloek J, Beijersbergen VH,. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol 1996; 64: 994-1000.